Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1526 to 1550 of 2491

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutationTA429
Sofosbuvir–velpatasvir for treating chronic hepatitis CTA430
Boston Keratoprosthesis Type I for corneal blindnessMIB91
CentriMag for heart failureMIB92
Ekso exoskeleton for rehabilitation in people with neurological weakness or paralysisMIB93
Refractory extrapulmonary sarcoidosis: infliximabES4
Smartinhaler for asthmaMIB90
Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomibTA427
TuberculosisQS141
Learning disability: identifying and managing mental health problemsQS142
Organ donation for transplantation: improving donor identification and consent rates for deceased organ donationCG135
Extracorporeal shockwave therapy for Achilles tendinopathyIPG571
Radiation therapy for early Dupuytren's diseaseIPG573
Dasatinib, nilotinib and high-dose imatinib for treating imatinib-resistant or intolerant chronic myeloid leukaemiaTA425
Dasatinib, nilotinib and imatinib for untreated chronic myeloid leukaemiaTA426
Everolimus with exemestane for treating advanced breast cancer after endocrine therapyTA421
Crizotinib for previously treated anaplastic lymphoma kinase-positive advanced non-small-cell lung cancerTA422
Eribulin for treating locally advanced or metastatic breast cancer after 2 or more chemotherapy regimensTA423
Pertuzumab for the neoadjuvant treatment of HER2-positive breast cancerTA424
Pulmonary sarcoidosis: infliximabES2
Blood transfusionQS138
Oral health promotion in the communityQS139
Hypothermia: prevention and management in adults having surgeryCG65
Epiduroscopic lumbar discectomy through the sacral hiatus for sciaticaIPG570
Ticagrelor for preventing atherothrombotic events after myocardial infarctionTA420

Results per page

  1. 10
  2. 25
  3. 50
  4. All